JFNSX
ETF
JFNSX
·
UNKNOWN
·
87 holdings
75,55 €
▲
1,43 €
(1,93%)
Day Range
—
52-Week Range
—
Volume
—
Ouverture —
Moyenne 50J / 200J
—
Moyenne 50J / 200J
—
About JFNSX
No description available for this ETF.
Fund Details
- Expense Ratio
- —
- Inception Date
- —
- Prev. Close
- 74,12 €
- Exchange
- UNKNOWN
- Currency
- USD
- Holdings As Of
- Apr 10, 2026
- Tracked Holdings
- 88.5%
- HHI Score
- 254,35
- Top Sector
- Healthcare (90.52231%)
Performance
Low (19,2%)
↗ Recovering
1W
▲ 1,98%
1M
▼ -0,11%
3M
▼ -1,03%
6M
▲ 14,28%
YTD
▼ -0,98%
1Y
▲ 27,66%
3Y
▲ 19,09%
Positive 1W (+1.98%) after negative 1M (-0.11%) — trend may be reversing
Price History
Concentration Risk
39,31%
Balanced
Diversified
Concentrated
The top 10 holdings represent 39,31% of the fund. A moderate concentration level — the fund balances top holdings with broader diversification.
Top Holdings Today
LLY
▼ -1,65%
JNJ
▼ -1,18%
AZN
▼ -0,47%
UNH
▼ -0,84%
ABBV
▼ -2,10%
ABT
▼ -2,36%
ARGX
▼ -0,11%
BSX
▲ 0,83%
SNYNF
▼ -1,49%
NVS
▼ -0,65%
Weighted avg. of top holdings
▼ -1,11%
Sector Allocation
Healthcare
90,52%
Manufacturing
3,02%
Top 10 Holdings
All Holdings (87)
Top 10: 39,31% of fund| # | Ticker | Name | Weight | Shares | Market Value |
|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly & Co. | 8,31% | 497 962 | 379,95 M |
| 2 | JNJ | Johnson & Johnson | 5,01% | 1,24 M | 229,16 M |
| 3 | AZN | AstraZeneca PLC | 4,22% | 1,26 M | 193,09 M |
| 4 | UNH | UnitedHealth Group Inc. | 4,21% | 556 891 | 192,29 M |
| 5 | ABBV | AbbVie Inc. | 3,58% | 706 535 | 163,59 M |
| 6 | ABT | Abbott Laboratories | 3,16% | 1,08 M | 144,64 M |
| 7 | ARGX | Argenx SE | 2,82% | 175 105 | 129,15 M |
| 8 | BSX | Boston Scientific Corporation | 2,74% | 1,29 M | 125,49 M |
| 9 | SNYNF | Sanofi SA | 2,69% | 1,30 M | 122,94 M |
| 10 | NVS | Novartis AG | 2,56% | 914 366 | 117,26 M |
Showing top 10 of 87 holdings
·
Listed: 97,52%
·
2,48% in other positions
Related ETFs
{"event":"ticker_viewed","properties":{"ticker":"JFNSX","listing_kind":"etf","pathname":"/etfs/jfnsx","exchange":"UNKNOWN"}}